Latest filing published 05 Jun 2025 for Hikma Pharmaceuticals PLC, €133k.
Filing timeline
BuySaleInsider track record
Dr Bill Larkins: trading record in brief
This profile gathers the share dealings of Dr Bill Larkins in Hikma Pharmaceuticals PLC. We count 2 filings; the first trade dates from 30 May 2025 and the latest from 4 June 2025.
Sales make up the whole of the open-market record (1 sale, €133k). The rest of the record consists of 1 share grant.
The record was last updated on 5 June 2025 with an open-market sale (€133k) in Hikma Pharmaceuticals PLC. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dr Bill Larkins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,257 shares@ £21.2861.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5684112
- 11,735 shares@ £21.3838.2% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5680033-7
2 of 2 declarations